Daniel O'Connor

• High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.

  O'Connor D. et al, (2017), Genome Med, 9, 11 - 11

• Non-specific immunological effects of selected routine childhood immunisations: systematic review.

  Kandasamy R. et al, (2016), BMJ, 355, i5225 - i5225

• Gene expression profiles are different in venous and capillary blood: Implications for vaccine studies.

  Stein DF. et al, (2016), Vaccine

• The use of systems biology and immunological big data to guide vaccine development.

  Blohmke CJ. et al, (2015), Genome Med, 7

• Searching for the human genetic factors standing in the way of universally effective vaccines.

  Mentzer AJ. et al, (2015), Philos Trans R Soc Lond B Biol Sci, 370

• Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine

  O'Connor D. et al, (2014), Vaccine, 32, 3424 - 3430

• Exonic single nucleotide polymorphisms within TLR3 associated with infant responses to serogroup C meningococcal conjugate vaccine.

  O'Connor D. et al, (2014), Vaccine, 32, 3424 - 3430

• The effect of chronic cytomegalovirus infection on pneumococcal vaccine responses.

  O'Connor D. et al, (2014), J Infect Dis, 209, 1635 - 1641

• Characterizing vaccine responses using host genomic and transcriptomic analysis.

  O'Connor D. and Pollard AJ., (2013), Clin Infect Dis, 57, 860 - 869

• Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis serogroups A, C, y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom

  Blanchard-Rohner G. et al, (2013), Pediatric Infectious Disease Journal, 32, 768 - 776

• Seroprevalence and placental transmission of maternal antibodies specific for Neisseria meningitidis Serogroups A, C, Y and W135 and influence of maternal antibodies on the immune response to a primary course of MenACWY-CRM vaccine in the United Kingdom.

  Blanchard-Rohner G. et al, (2013), Pediatr Infect Dis J, 32, 768 - 776

• Genetic material should be routinely collected in clinical vaccine trials--high consent rates can be achieved across all age groups.

  Trück J. et al, (2013), Vaccine, 31, 2744 - 2748

• The B-cell response to a primary and booster course of MenACWY-CRM₁₉₇ vaccine administered at 2, 4 and 12 months of age.

  Blanchard-Rohner G. et al, (2013), Vaccine, 31, 2441 - 2448

• Single nucleotide polymorphisms in the toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine

  Moore CE. et al, (2012), Clinical and Vaccine Immunology, 19, 295 - 303

• Single nucleotide polymorphisms in the Toll-like receptor 3 and CD44 genes are associated with persistence of vaccine-induced immunity to the serogroup C meningococcal conjugate vaccine.

  Moore CE. et al, (2012), Clin Vaccine Immunol, 19, 295 - 303

Recent Publications

• High-dimensional assessment of B-cell responses to quadrivalent meningococcal conjugate and plain polysaccharide vaccine.

  O'Connor D. et al, (2017), Genome Med, 9, 11 - 11

• Non-specific immunological effects of selected routine childhood immunisations: systematic review.

  Kandasamy R. et al, (2016), BMJ, 355, i5225 - i5225

• Gene expression profiles are different in venous and capillary blood: Implications for vaccine studies.

  Stein DF. et al, (2016), Vaccine

• The use of systems biology and immunological big data to guide vaccine development.

  Blohmke CJ. et al, (2015), Genome Med, 7

• Searching for the human genetic factors standing in the way of universally effective vaccines.

  Mentzer AJ. et al, (2015), Philos Trans R Soc Lond B Biol Sci, 370